Studies have demonstrated that CSNK2B is essential for the kinase activity of CK2, and overexpression of CSNK2B has been reported to promote HCC tumorigenesis via trans-activation of NF-κB [20, 21]. Here, NFKB1 is linked to hepatocellular carcinoma.